365 related articles for article (PubMed ID: 20947621)
1. Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.
de Steenwinkel JE; de Knegt GJ; ten Kate MT; van Belkum A; Verbrugh HA; Kremer K; van Soolingen D; Bakker-Woudenberg IA
J Antimicrob Chemother; 2010 Dec; 65(12):2582-9. PubMed ID: 20947621
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.
Gumbo T; Louie A; Liu W; Brown D; Ambrose PG; Bhavnani SM; Drusano GL
Antimicrob Agents Chemother; 2007 Jul; 51(7):2329-36. PubMed ID: 17438043
[TBL] [Abstract][Full Text] [Related]
4. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
Matee M; Mfinanga S; Holm-Hansen C
APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. [Drug resistance of Mycobacterium tuberculosis in a nationwide epidemiological survey in China in the year of 2000].
Liu Y; Jiang G; Zhao L; Fu Y; Li Y; Bi Z; Wang S
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Apr; 25(4):224-7. PubMed ID: 12133331
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance.
Gumbo T; Louie A; Deziel MR; Drusano GL
Antimicrob Agents Chemother; 2005 Aug; 49(8):3178-81. PubMed ID: 16048921
[TBL] [Abstract][Full Text] [Related]
8. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis.
Abbadi SH; Sameaa GA; Morlock G; Cooksey RC
Int J Infect Dis; 2009 Nov; 13(6):673-8. PubMed ID: 19138546
[TBL] [Abstract][Full Text] [Related]
9. [Impact of drug resistance on the fitness of Mycobacteruim tuberculosis of the genotype W-Beijing].
Tungusova OS; Mar'iandyshev AO; Kaugant DA; Sandven P; Bjeune G
Probl Tuberk Bolezn Legk; 2005; (8):46-50. PubMed ID: 16209021
[No Abstract] [Full Text] [Related]
10. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
[TBL] [Abstract][Full Text] [Related]
11. Molecular snapshot of drug-resistant and drug-susceptible Mycobacterium tuberculosis strains circulating in Bulgaria.
Valcheva V; Mokrousov I; Narvskaya O; Rastogi N; Markova N
Infect Genet Evol; 2008 Sep; 8(5):657-63. PubMed ID: 18657631
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
[TBL] [Abstract][Full Text] [Related]
13. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.
Palomino JC; Martin A; Von Groll A; Portaels F
J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779
[TBL] [Abstract][Full Text] [Related]
14. The ins and outs of Mycobacterium tuberculosis drug susceptibility testing.
Böttger EC
Clin Microbiol Infect; 2011 Aug; 17(8):1128-34. PubMed ID: 21631641
[TBL] [Abstract][Full Text] [Related]
15. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
Shenai S; Rodrigues C; Mehta A
Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
[TBL] [Abstract][Full Text] [Related]
16. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India.
Jadaun GP; Das R; Upadhyay P; Chauhan DS; Sharma VD; Katoch VM
Int J Antimicrob Agents; 2009 May; 33(5):483-6. PubMed ID: 19112008
[TBL] [Abstract][Full Text] [Related]
17. Drug susceptibility pattern of Mycobacterium tuberculosis in adult patients with miliary tuberculosis.
Irfan M; Hussain SF; Jabeen K; Islam M
Trop Doct; 2007 Jul; 37(3):182-4. PubMed ID: 17716515
[TBL] [Abstract][Full Text] [Related]
18. [Molecular-genetic method of identification of drug-resistant Mycobacterium tuberculosis].
Dubileĭ SA; Ignatova AN; Shemiakin IG
Mol Gen Mikrobiol Virusol; 2005; (1):3-7. PubMed ID: 15790026
[TBL] [Abstract][Full Text] [Related]
19. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
[TBL] [Abstract][Full Text] [Related]
20. Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.
Bax HI; de Steenwinkel JE; Ten Kate MT; van der Meijden A; Verbon A; Bakker-Woudenberg IA
J Antimicrob Chemother; 2015 Oct; 70(10):2828-37. PubMed ID: 26183185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
